美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	212299	002	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	50MG/25ML (2MG/ML)	No	No	2020/09/10	2020/09/10	ZYDUS LIFESCIENCES	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	207228	001	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	20MG/10ML (2MG/ML)	No	No	2021/10/12	2021/10/12	AYANA PHARMA LTD	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	207228	002	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	50MG/25ML (2MG/ML)	No	No	2021/10/12	2021/10/12	AYANA PHARMA LTD	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	212219	001	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	20MG/10ML (2MG/ML)	No	No	2022/10/19	2022/10/19	BAXTER HLTHCARE CORP	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	212219	002	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	50MG/25ML (2MG/ML)	No	No	2022/10/19	2022/10/19	BAXTER HLTHCARE CORP	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	215178	001	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	20MG/10ML (2MG/ML)	No	No	2024/07/16	2024/07/16	LUPIN	Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)	215178	002	ANDA	DOXORUBICIN HYDROCHLORIDE	INJECTABLE, LIPOSOMAL;INJECTION	50MG/25ML (2MG/ML)	No	No	2024/07/16	2024/07/16	LUPIN	Prescription